Post by Merck on XMerck@MerckXToday, we announced positive topline results from our late-stage clinical study in respiratory syncytial virus (#RSV) disease. Learn more: t.coShown as X shows it.Open on X 25 likes2 repliesPosted Jul 23, 2024